Expression of p53 in recurrent nodal metastasis from nasopharyngeal carcinoma (NPC)

被引:14
作者
Chow, LWC
Khoo, US
Yuen, APW
Wei, WI
机构
[1] UNIV HONG KONG,MED CTR,DEPT SURG,QUEEN MARY HOSP,HONG KONG,HONG KONG
[2] UNIV HONG KONG,QUEEN MARY HOSP,MED CTR,DEPT PATHOL,HONG KONG,HONG KONG
来源
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY | 1997年 / 23卷 / 05期
关键词
p53; expression; nasopharyngeal carcinoma; recurrent nodal metastasis;
D O I
10.1016/S0748-7983(97)93721-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study reports the incidence of p53 expression in 40 patients with recurrent nodal metastasis from nasopharyngeal carcinoma (NPC) and its prognostic value in this group of patients. Immunohistochemical staining using monoclonal antibody specific for human p53 protein was performed on the tumour-bearing nodes from 40 patients. The results were divided into four grades (I, negative; II, < 10% of cells positive; III, 10-50% of cells positive; and IV, > 50% of cells positive). The staining scores sere correlated with histological tumour types, subsequent recurrence and survival. AII patients had undergone neck irradiation. Lymph node specimens from six patients (15%) showed positive staining of nuclear p53 protein. The distribution among the different grades was: three (7.5%) for II, two (5%) for III and one (2.5%) for IV. Patients with p53-overexpressed tumours had a significantly higher number of tumour-bearing lymph nodes, There was no correlation of p53 expression with histological tumour types, second tumour recurrence and survival. Expression of p53 appears to be uncommon in patients with recurrent nodal metastases in NPC. It did not have prognostic value in this particular series of patients.
引用
收藏
页码:415 / 418
页数:4
相关论文
共 19 条
[1]   ALTERATIONS OF THE P53 GENE IN NASOPHARYNGEAL CARCINOMA [J].
EFFERT, P ;
MCCOY, R ;
ABDELHAMID, M ;
FLYNN, K ;
ZHANG, Q ;
BUSSON, P ;
TURSZ, T ;
LIU, E ;
RAABTRAUB, N .
JOURNAL OF VIROLOGY, 1992, 66 (06) :3768-3775
[2]  
FOX R, 1986, SURG CLIN N AM, V66, P97
[3]   P53 MUTATIONS IN HUMAN CANCERS [J].
HOLLSTEIN, M ;
SIDRANSKY, D ;
VOGELSTEIN, B ;
HARRIS, CC .
SCIENCE, 1991, 253 (5015) :49-53
[4]  
HSU MM, 1983, CANCER-AM CANCER SOC, V52, P362, DOI 10.1002/1097-0142(19830715)52:2<362::AID-CNCR2820520230>3.0.CO
[5]  
2-V
[6]   P53 - ONCOGENE OR ANTI-ONCOGENE [J].
LANE, DP ;
BENCHIMOL, S .
GENES & DEVELOPMENT, 1990, 4 (01) :1-8
[7]   P53 MUTATIONS INCREASE RESISTANCE TO IONIZING-RADIATION [J].
LEE, JM ;
BERNSTEIN, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (12) :5742-5746
[8]  
LO KW, 1992, ANTICANCER RES, V12, P1957
[9]  
MUIR C, 1987, CANC INCIDENCE 5 CON, V5, P840
[10]   A MOLECULAR STUDY OF EBV DNA AND P53 MUTATIONS IN NASOPHARYNGEAL CARCINOMA OF SAUDI-ARAB PATIENTS [J].
NASRIN, N ;
TAIBA, K ;
HANNAN, NHM ;
ALSEDAIRY, S .
CANCER LETTERS, 1994, 82 (02) :189-198